Synthesis method of BTK inhibitor pitobubrutinib
Through the 5-step reaction synthesis method, the yield of pitobrutinib is increased by using ammonia borane and concentrated sulfuric acid, solving the problems of complex and low synthesis in the prior art, and achieving efficient and economical pitobrutinib Rutinib is produced.
Patent Information
- Application Number
- CN202411100883.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-12
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-08-12
AI Technical Summary
In the prior art, the synthesis method of pitobrutinib is complex and has a low yield, making it difficult to meet the needs of industrial production.
The 5-step reaction synthesis method was adopted to convert the ester group into amide using amide using ammonia borane, shorten the reaction step, and use concentrated sulfuric acid in the last step to increase the yield of cyano group conversion to amide.
The synthesis route is simplified, the yield is improved, from 80% to 89.5%, reducing the difficulty of purification, has good economic benefits and operability, and is suitable for large-scale industrial production.
Smart Images

Figure BDA0004989341670000011 
Figure BDA0004989341670000021 
Figure BDA0004989341670000091
Abstract
Description
Technical Field
[0001] The present invention relates to the field of biomedicine technology, and in particular to a method for synthesizing BTK inhibitor Pitobrutinib. Background Art
[0002] Pirtobrutinib (also known as Pirtobrutinib, R&D code: LOXO-305, trade name: Jaypirca) is a small molecule BTK inhibitor. On January 27, 2023, Eli Lilly announced that the U.S. FDA accelerated the approval of its new generation BTK inhibitor, Pirtobrutinib, for adult patients with relapsed or refractory mantle cell lymphoma (MCL) who have received at least two lines of systemic treatment (including BTK inhibitors). Pirobrutinib is also the first and so far the only non-covalent (reversible) BTK inhibitor approved by the U.S. FDA. The previously marketed BTK small molecule inhibitors are all covalent BTK inhibitors, which mainly produce enzyme inhibition by forming covalent bonds with cysteine residues in the BTK active site, but covalent binding is prone to drug-resistant mutations. Pirobrutinib can reestablish BTK inhibition in MCL patients who have previously been treated with covalent BTK inhibitors (ibrutinib, acalabrutinib, or zanubrutinib).
[0003] The chemical structure of Pitobrutinib is shown in Formula I:
[0004]
[0005] However, the current synthetic methods for pirobrutinib still need to be improved. Summary of the invention
[0006] The present invention aims to solve one of the technical problems in the related art at least to a certain extent. To this end, one object of the present invention is to propose a method for synthesizing the compound Pitobrutinib shown in Formula I. Compared with the prior art, the steps of this route are shortened to 5 steps. The present invention directly uses ammonia borane to convert the ester group into an amide, which can shorten one or two steps of the reaction. The subsequent substitution reaction of the amide in the present invention can effectively improve the yield. In the last step, compared with the general use of methanesulfonic acid in the literature to convert the cyano group into an amide, the present invention replaces the acid with concentrated sulfuric acid, and the reaction yield can be increased from about 80% yield in the prior art to 89.5% yield in the present invention.
[0007] In one aspect of the present invention, the present invention provides a method for synthesizing Pitobrutinib, a compound of Formula I. According to an embodiment of the present invention, the synthesis method comprises:
[0008] (1) contacting the compound represented by Formula 1, methyl iodide, and an acid-binding agent A to obtain the compound represented by Formula 2;
[0009] (2) contacting the compound represented by Formula 2 with ammonia borane (NH3BH3) and sodium bis(trimethylsilyl)amide to obtain the compound represented by Formula 3;
[0010] (3) contacting the compound represented by Formula 3, pentamethyldiethylenetriamine (PMDETA), copper bromide, an organic base B, and the compound represented by Formula 7 to obtain the compound represented by Formula 4;
[0011] (4) contacting the compound represented by Formula 4, the compound represented by Formula 5, Pd(dppf)Cl2, and an inorganic salt C to obtain the compound represented by Formula 6;
[0012] (5) contacting the compound of formula 5 with concentrated sulfuric acid to obtain the compound of formula I, Pitobrutinib,
[0013]
[0014] The inventors have found that, using the synthesis method of the present invention, with the compound of Formula 1 and methyl iodide as starting materials, a total of 5 steps of reaction can be performed to successfully synthesize the target product, Pitobrutinib.
[0015] The term "contact" as used herein should be understood in a broad sense, and can be any manner that allows at least two reactants to undergo a chemical reaction, such as mixing the two reactants under appropriate conditions. If necessary, the reactants to be contacted can be mixed under stirring, and thus, the type of stirring is not particularly limited, and can be mechanical stirring, i.e. stirring under the action of mechanical force.
[0016] In this document, the terms "first" and "second" are used for descriptive purposes only and should not be understood as indicating or implying relative importance or implicitly indicating the number of the indicated technical features. Thus, a feature defined as "first" or "second" may explicitly or implicitly include one or more of the features. In the description of the present invention, the meaning of "plurality" is two or more, unless otherwise clearly and specifically defined.
[0017] According to an embodiment of the present invention, the method for preparing the compound shown in Formula 2, the compound shown in Formula 3, the compound shown in Formula 4, the compound shown in Formula 6, and the compound shown in Formula I may also have at least one of the following additional technical features:
[0018] According to an embodiment of the present invention, the chemical reaction described in the present invention can be carried out according to any method known in the art. The source of the raw materials of the compound shown in Formula 2, the compound shown in Formula 3, the compound shown in Formula 4, the compound shown in Formula 6, and the compound shown in Formula 1 is not particularly limited, and it can be prepared by any known method or commercially available. For example, the CAS of the compound shown in Formula 1 is: 345-16-4, and the CAS of the compound shown in Formula 5 is: 2764851-21-8.
[0019] According to an embodiment of the present invention, in step (1), the contacting method of the compound represented by Formula 1, methyl iodide and acid-binding agent A is not particularly limited. Thus, the efficiency of the contact reaction of the compound represented by Formula 1, methyl iodide and acid-binding agent A can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound represented by Formula 2 by using this method can be further improved.
[0020] According to an embodiment of the present invention, in step (1), the following steps are included: sealing a reaction system containing the compound shown in Formula 1, methyl iodide, an acid-binding agent A and DMF, reacting at 100° C. for 10 hours, cooling the reaction system after the reaction is completed, performing post-treatment, quenching with a saturated ammonium chloride solution, adding ethyl acetate to dilute, washing the organic phase with water and saturated brine in sequence, drying with anhydrous sodium sulfate, and decompressing the filtrate to remove the solvent, thereby obtaining the compound shown in Formula 2. Thus, the efficiency of the contact reaction of the compound shown in Formula 1, methyl iodide and the acid-binding agent A can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in Formula 2 using this method can be further improved.
[0021] According to an embodiment of the present invention, in step (1), the molar ratio of the compound represented by Formula 1, methyl iodide, and acid-binding agent A is 1:4:(4.0-5.0), and preferably the molar ratio of the compound represented by Formula 1, methyl iodide, and acid-binding agent A is 1:4:4.5. Thus, the efficiency of preparing the compound represented by Formula 2 by this method can be further improved.
[0022] According to an embodiment of the present invention, in step (1), the acid-binding agent A is at least one selected from potassium carbonate, N,N-diisopropylethylamine, N,N-diisopropylethylenediamine or triethylamine.
[0023] According to a specific embodiment of the present invention, in step (1), the following steps are included: sealing a reaction system containing the compound shown in formula 1 (1.56 g, 0.01 mol), iodomethane (5.68 g, 0.04 mol), potassium carbonate (6.22 g, 0.045 mol) and DMF (50 mL), reacting at 100° C. for 10 hours, cooling the reaction system after the reaction is completed, quenching with saturated ammonium chloride solution (10 mL), adding ethyl acetate (50 mL) to dilute, washing the organic phase with water (50 mL) and saturated brine (50 mL) in turn, drying over anhydrous sodium sulfate, and distilling off the solvent from the filtrate under reduced pressure to obtain the compound shown in formula 2, with an amount of 1.810 g and a yield of 98.3%.
[0024] According to an embodiment of the present invention, in step (2), the contacting method of the compound shown in Formula 2 with ammonia borane (NH3BH3) and sodium bis(trimethylsilyl)amide (NaHMDS) is not particularly limited. Thus, the efficiency of the contact reaction between the compound shown in Formula 2 and NH3BH3 and sodium bis(trimethylsilyl)amide can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in Formula 3 by using this method can be further improved.
[0025] According to an embodiment of the present invention, in step (2), the following steps are included: adding the compound shown in Formula 2, NH3BH3, sodium bis(trimethylsilyl)amide, and THF solution to the Schlenk tube in sequence, sealing the Schlenk tube, stirring and reacting at 25°C under a nitrogen atmosphere for 14 to 18 minutes, adding water to quench the reaction after the reaction is completed, extracting with ethyl acetate, combining the organic phases, drying with anhydrous sodium sulfate, concentrating under reduced pressure to remove the organic solvent, directly filtering, and separating to obtain the compound shown in Formula 3. Thus, the efficiency of the contact reaction between the compound shown in Formula 2 and NH3BH3 and sodium bis(trimethylsilyl)amide can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in Formula 3 using this method can be further improved.
[0026] According to an embodiment of the present invention, in step (2), the molar ratio of the compound shown in formula 2 to NH3BH3 and sodium bis(trimethylsilyl)amide is 1:(1.1-1.2):(1.4-1.6), and preferably the molar ratio of the compound shown in formula 2 to NH3BH3 and sodium bis(trimethylsilyl)amide is 1:1.15:1.5. Thus, the efficiency of preparing the compound shown in formula 3 by this method can be further improved.
[0027] According to an embodiment of the present invention, in step (2), the reaction is preferably stirred for 15 minutes.
[0028] According to a specific embodiment of the present invention, in step (2), the following steps are included: to a 50mL Schlenk tube, the compound represented by formula 2 (1.84g, 0.01mol), NH3BH3 (0.355g, 0.0115mol), sodium bis(trimethylsilyl)amide (2.75g, 0.015mol), and THF solution (20ml) are added in sequence, the Schlenk tube is sealed, and the reaction is stirred at 25°C under a nitrogen atmosphere for 15 minutes. After the reaction is completed, water (10mL) is added to quench the reaction, and the mixture is extracted with ethyl acetate (20mL×2), the organic phases are combined, dried over anhydrous sodium sulfate, concentrated under reduced pressure to remove the organic solvent, and directly filtered to separate the solid of the compound represented by formula 3, with an amount of 1.52g and a yield of 89.8%.
[0029] According to an embodiment of the present invention, in step (3), the contacting method of the compound shown in Formula 3, pentamethyldiethylenetriamine (PMDETA), copper bromide, organic base B, and the compound shown in Formula 7 is not particularly limited. Thus, the efficiency of the contact reaction of the compound shown in Formula 3, pentamethyldiethylenetriamine, copper bromide, organic base B, and the compound shown in Formula 7 can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in Formula 4 by using this method can be further improved.
[0030] According to an embodiment of the present invention, in step (3), the following steps are included: at room temperature, toluene and pentamethyldiethylenetriamine are added to a flask containing copper bromide, organic base B and the compound shown in formula 3, and under N2 protection, a mixed solution of the compound shown in formula 7 and toluene is slowly added dropwise, and the dripping is completed in 30 minutes. After the dripping is completed, the reaction mixture is stirred at room temperature for 8 to 9 hours, and after the reaction is completed, ethyl acetate is added to dilute, the organic phase is washed with water and saturated brine in sequence, and dried over anhydrous sodium sulfate, the filtrate is concentrated under reduced pressure to evaporate the solvent, and the concentrate is purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of (8 to 12): 1 to obtain the compound shown in formula 4. Thus, the efficiency of the contact reaction of the compound shown in formula 3, pentamethyldiethylenetriamine, copper bromide, potassium tert-butoxide, and the compound shown in formula 7 can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in formula 4 using this method can be further improved.
[0031] According to an embodiment of the present invention, in step (3), the molar ratio of the compound shown in formula 3, pentamethyldiethylenetriamine, copper bromide, organic base B, and the compound shown in formula 7 is 1: (0.04-0.05): (0.04-0.05): (1.1-1.2): (1.0-1.2), preferably the molar ratio of the compound shown in formula 3, pentamethyldiethylenetriamine, copper bromide, organic base B, and the compound shown in formula 7 is 1: 0.045: 0.045: 1.15: 1.1. Thus, the efficiency of preparing the compound shown in formula 4 by this method can be further improved.
[0032] According to an embodiment of the present invention, in step (3), the organic base B is at least one selected from potassium tert-butoxide, sodium tert-butoxide or butyl lithium.
[0033] According to an embodiment of the present invention, in step (3), the reaction mixture is preferably stirred at room temperature for 8.5 hours.
[0034] According to an embodiment of the present invention, in step (3), the volume ratio of petroleum ether / ethyl acetate mixed solvent is preferably 10:1.
[0035] According to a specific embodiment of the present invention, in step (3), the following steps are included: at room temperature, toluene (200 mL) and pentamethyldiethylenetriamine (7.80 g, 0.045 mol) are added to a flask containing copper bromide (10.05 g, 0.045 mol), potassium tert-butoxide (12.90 g, 0.115 mol) and the compound shown in Formula 3 (16.92 g, 0.1 mol), and under N2 protection, the compound shown in Formula 7 (22.60 g, 0.11 mol) is slowly added dropwise. ) and toluene (80mL) were added and the mixture was added dropwise for 30 minutes. After the addition, the reaction mixture was stirred at room temperature for 8.5 hours. After the reaction was completed, ethyl acetate (200ml) was added for dilution. The organic phase was washed with water (200mL) and saturated brine (200mL) in turn, and dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent. The concentrate was purified by silica gel column chromatography using a mixed solvent of petroleum ether / ethyl acetate in a volume ratio of 10:1 to obtain the compound shown in formula 4. The yield was 22.59 g, and the yield was 76.9%.
[0036] According to an embodiment of the present invention, in step (4), the contacting method of the compound represented by Formula 4, the compound represented by Formula 5, Pd(dppf)Cl2, and the inorganic salt C is not particularly limited. Thus, the efficiency of the contacting reaction of the compound represented by Formula 4, the compound represented by Formula 5, Pd(dppf)Cl2, and the inorganic salt C can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound represented by Formula 6 by using this method can be further improved.
[0037] According to an embodiment of the present invention, in step (4), the following steps are included: under N2 protection, the compound shown in formula 4, the compound shown in formula 5, Pd (dppf) Cl2 and inorganic salt C solution are added to a flask containing DMF, the reaction mixture is heated to 84°C to 92°C for reaction for 11.5 hours to 13 hours, after the reaction, the reaction solution is cooled to room temperature, the reaction solution is filtered through diatomaceous earth and then washed with water, the aqueous phase is extracted with ethyl acetate, the organic phases are combined and then washed with saturated brine, dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the concentrate is purified by silica gel column chromatography with a petroleum ether / ethyl acetate mixed solvent with a volume ratio of (2 to 6): 1 to obtain the compound shown in formula 6. Thus, the efficiency of the contact reaction of the compound shown in formula 4, the compound shown in formula 5, Pd (dppf) Cl2 and inorganic salt C can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound shown in formula 6 by using this method can be further improved.
[0038] According to an embodiment of the present invention, in step (4), the molar ratio of the compound represented by Formula 4, the compound represented by Formula 5, Pd(dppf)Cl2, and the inorganic salt C is 1:(1.0-1.2):(0.1-0.2):15, and preferably the molar ratio of the compound represented by Formula 4, the compound represented by Formula 5, Pd(dppf)Cl2, and the inorganic salt C is 1:1.1:0.15:15. Thus, the efficiency of preparing the compound represented by Formula 6 by using this method can be further improved.
[0039] According to an embodiment of the present invention, in step (4), the inorganic salt C is at least one selected from sodium bicarbonate or potassium bicarbonate.
[0040] According to an embodiment of the present invention, in step (4), the reaction mixture is preferably heated to 86° C. to 90° C. for 12 hours.
[0041] According to an embodiment of the present invention, in step (4), the volume ratio of petroleum ether / ethyl acetate mixed solvent is preferably 4:1.
[0042] According to a specific embodiment of the present invention, in step (4), the following steps are included: under N2 protection, the compound represented by formula 4 (29.4 g, 0.1 mol), the compound represented by formula 5 (27.3 g, 0.11 mol), Pd(dppf)Cl2 (10.98 g, 0.015 mol) and sodium bicarbonate solution (containing 126 g (1.5 mol) of sodium bicarbonate, prepared into a 1 M solution) are added to a flask containing DMF (300 mL), and the reaction mixture is heated to 400 °C. The mixture was heated to 86°C to 90°C for reaction for 12 hours. After the reaction, the reaction solution was cooled to room temperature, filtered through diatomaceous earth and washed with water (500 mL). The aqueous phase was extracted with ethyl acetate (500 mL×2). The organic phases were combined and washed with saturated brine (500 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 4:1 to obtain the compound represented by formula 6, with an amount of 35.71 g and a yield of 77.4%.
[0043] According to an embodiment of the present invention, in step (5), the contacting method of the compound represented by Formula 6 and concentrated sulfuric acid is not particularly limited. Thus, the efficiency of the contact reaction between the compound represented by Formula 6 and concentrated sulfuric acid can be improved, the reaction speed can be accelerated, and the efficiency of preparing the compound represented by Formula I by using this method can be further improved.
[0044] According to an embodiment of the present invention, in step (5), the following steps are included: adding the compound shown in Formula 6 and toluene to the reaction bottle, controlling the temperature below 20°C, slowly dripping concentrated sulfuric acid, and after dripping, the mixed solution is heated to 60°C, vigorously stirred and reacted for 3 hours, and after the reaction solution is cooled, post-processing is performed, slowly adding ice saturated NaHCO3 solution, and then adding ethyl acetate, DCM and THF:EtOAc (v / v=1:1) respectively for extraction, adding saturated brine to wash the organic phase after merging, drying with anhydrous sodium sulfate, and concentrating under reduced pressure to obtain a solid, and the solid is recrystallized with a mixed solvent of ethyl acetate and hexane, filtered, and the filter cake is dried to obtain the compound shown in Formula I, Pitobrutinib. Thus, the efficiency of the contact reaction between the compound shown in Formula 6 and concentrated sulfuric acid can be improved, the reaction rate can be accelerated, and the efficiency of preparing the compound shown in Formula I by using this method can be further improved.
[0045] According to an embodiment of the present invention, in step (5), the molar ratio of the compound represented by Formula 6 to concentrated sulfuric acid is 1:(8-10), preferably, the molar ratio of the compound represented by Formula 6 to concentrated sulfuric acid is 1:9. Thus, the efficiency of preparing the compound represented by Formula I by this method can be further improved.
[0046] According to an embodiment of the present invention, in step (5), the volume ratio of ethyl acetate to hexane in the mixed solvent of ethyl acetate and hexane is (5-8):1, preferably the volume ratio of ethyl acetate to hexane is 6:1.
[0047] According to a specific embodiment of the present invention, in step (5), the following steps are included: adding the compound represented by formula 6 (46.14 g, 0.1 mol) and toluene (500 ml) to a reaction bottle, controlling the temperature below 20°C, slowly dropping concentrated sulfuric acid (88.2 g, 0.9 mol), after the dropping is completed, the mixed solution is heated to 60°C, stirred vigorously for 3 hours, and after the reaction solution is cooled, slowly adding an ice-saturated NaHCO3 (600 ml) solution, and then adding ethyl acetate (2×600 mL ), DCM (2×600 mL) and THF:EtOAc (v / v=1:1, 2×600 mL) were used for extraction, the organic phases were combined, washed with saturated brine (600 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid, which was recrystallized with a mixed solvent of ethyl acetate and hexane (the volume ratio of ethyl acetate to hexane was 6:1), filtered, and the filter cake was dried to obtain the compound of formula I, pitobrutinib, with an yield of 42.91 g, a yield of 89.5%, and a HPLC purity of 99.6%.
[0048] According to a specific embodiment of the present invention, the synthesis route of the compound Pitobrutinib represented by Formula I can be as follows:
[0049]
[0050] Compared with the prior art, the synthesis method of the BTK small molecule inhibitor Pitobrutinib described in the present invention has at least the following beneficial effects:
[0051] 1. Innovation in the reaction steps: In step (1), the compound of formula 1 undergoes a substitution reaction with methyl iodide to obtain a compound of formula 2; in step (2), the compound of formula 2 reacts with ammonia borane (NH3BH3) to form an amide to obtain a compound of formula 3; in step (3), the compound of formula 3 undergoes an alkylation reaction with a halogenated hydrocarbon under an alkaline environment to obtain a compound of formula 4; in step (4), the compound of formula 4 and the compound of formula 5 react under the presence of Pd as a catalyst. Occurs under chemical conditions Suzuki coupling reaction to obtain the compound shown in Formula 6; in step (5), the compound shown in Formula 6 The cyano group in the product reacts under strong acid (H2SO4) conditions to generate the product Pitobrutinib. Compared with the common literature synthesis routes, which are mostly more than 8 steps, the steps of this route are shortened, from the 8-step reaction of the prior art to the 5-step reaction of the present invention.
[0052] 2. Innovation of technical effect: The starting material of the present invention selects 5-fluoro-2-hydroxy-benzoic acid, which is about 20% cheaper than 5-fluoro-2-methoxy-benzoic acid, and has good economic benefits; relative to the need to first convert 5-fluoro-2-methoxy-benzoic acid methyl ester into the corresponding benzoic acid and then react with the amine group to obtain amide when converting it to amide, the present invention directly uses ammonia borane (NH3BH3) to convert the ester group into amide, which can shorten one or two steps of reaction. The present invention subsequently carries out the substitution reaction of amide, which can effectively improve the yield. In the last step, relative to the general use of methanesulfonic acid to convert cyano group into amide in the literature, the present invention replaces acid with concentrated sulfuric acid, and the reaction yield can be increased from about 80% yield of the prior art to 89.5% yield of the present invention. In addition, the purification of the five-step reaction mostly adopts the method of recrystallization, avoids the purification method of column chromatography, reduces the difficulty of purification, and has good economy and operability.
[0053] 3. In summary, this route has the advantages of low raw material cost, high yield, simple purification, etc. It is easy to industrialize and is very suitable for large-scale industrial production. DETAILED DESCRIPTION
[0054] The embodiments of the present invention are described in detail below. The embodiments described below are exemplary and are only used to explain the present invention, and should not be construed as limiting the present invention. If no specific techniques or conditions are specified in the embodiments, the techniques or conditions described in the literature in this area or the product specifications are used. The reagents or instruments used that do not specify the manufacturer are all conventional products that can be obtained commercially.
[0055] Example 1 Synthesis of the compound represented by formula 2
[0056] A reaction system containing the compound of Formula 1 (1.56 g, 0.01 mol), iodomethane (5.68 g, 0.04 mol), potassium carbonate (6.22 g, 0.045 mol) and DMF (50 mL) was sealed and reacted at 100° C. for 10 hours. After the reaction, the reaction system was cooled and quenched with saturated ammonium chloride solution (10 mL). Ethyl acetate (50 mL) was added to dilute the reaction system. The organic phase was washed with water (50 mL) and saturated brine (50 mL) in turn, and dried over anhydrous sodium sulfate. The solvent was evaporated from the filtrate under reduced pressure to obtain the compound of Formula 2. The yield was 1.810 g and the yield was 98.3%.
[0057] LC-MS (APCI): m / z = 185.2 (M+1) + .
[0058] 1H-NMR (300MHz, CDCl3): δ7.5 (m, 1H), 7.17 (m, 1H), 6.91 (dd, 1H), 3.88 (d, 6H).
[0059] Example 2 Synthesis of the compound represented by formula 2
[0060] A reaction system containing the compound of Formula 1 (1.56 g, 0.01 mol), iodomethane (5.68 g, 0.04 mol), potassium carbonate (5.53 g, 0.04 mol) and DMF (50 mL) was sealed and reacted at 100° C. for 10 hours. After the reaction, the reaction system was cooled and quenched with saturated ammonium chloride solution (10 mL). Ethyl acetate (50 mL) was added to dilute the reaction system. The organic phase was washed with water (50 mL) and saturated brine (50 mL) in turn, and dried over anhydrous sodium sulfate. The solvent was evaporated from the filtrate under reduced pressure to obtain the compound of Formula 2. The yield was 1.805 g and the yield was 98.0%.
[0061] Example 3 Synthesis of the compound represented by formula 2
[0062] A reaction system containing the compound of Formula 1 (1.56 g, 0.01 mol), iodomethane (5.68 g, 0.04 mol), potassium carbonate (6.91 g, 0.05 mol) and DMF (50 mL) was sealed and reacted at 100° C. for 10 hours. After the reaction, the reaction system was cooled and quenched with saturated ammonium chloride solution (10 mL). Ethyl acetate (50 mL) was added to dilute the reaction system. The organic phase was washed with water (50 mL) and saturated brine (50 mL) in turn, and dried over anhydrous sodium sulfate. The solvent was evaporated from the filtrate under reduced pressure to obtain the compound of Formula 2. The yield was 1.790 g and the yield was 97.2%.
[0063] Example 4 Synthesis of the compound represented by formula 2
[0064] Experiment of replacing acid binding agent A with N,N-diisopropylethylamine:
[0065] A reaction system containing the compound of Formula 1 (1.56 g, 0.01 mol), iodomethane (5.68 g, 0.04 mol), N,N-diisopropylethylamine (5.82 g, 0.045 mol) and DMF (50 mL) was sealed and reacted at 100° C. for 10 hours. After the reaction, the reaction system was cooled and quenched with saturated ammonium chloride solution (10 mL). Ethyl acetate (50 mL) was added to dilute the reaction system. The organic phase was washed with water (50 mL) and saturated brine (50 mL) in turn, and dried over anhydrous sodium sulfate. The solvent was evaporated from the filtrate under reduced pressure to obtain the compound of Formula 2. The yield was 1.801 g and the yield was 97.8%.
[0066] Example 5 Synthesis of the compound represented by formula 2
[0067] Experiment of replacing acid binding agent A with N,N-diisopropylethylenediamine:
[0068] A reaction system containing the compound of Formula 1 (1.56 g, 0.01 mol), iodomethane (5.68 g, 0.04 mol), N,N-diisopropylethylenediamine (6.49 g, 0.045 mol) and DMF (50 mL) was sealed and reacted at 100° C. for 10 hours. After the reaction, the reaction system was cooled and quenched with saturated ammonium chloride solution (10 mL). Ethyl acetate (50 mL) was added to dilute the reaction system. The organic phase was washed with water (50 mL) and saturated brine (50 mL) in turn, and dried over anhydrous sodium sulfate. The solvent was evaporated from the filtrate under reduced pressure to obtain the compound of Formula 2. The yield was 1.796 g and the yield was 97.5%.
[0069] Example 6 Synthesis of the compound represented by formula 2
[0070] Experiment of replacing acid binding agent A with triethylamine:
[0071] A reaction system containing the compound of Formula 1 (1.56 g, 0.01 mol), iodomethane (5.68 g, 0.04 mol), triethylamine (6.49 g, 0.045 mol) and DMF (50 mL) was sealed and reacted at 100° C. for 10 hours. After the reaction, the reaction system was cooled and quenched with saturated ammonium chloride solution (10 mL). Ethyl acetate (50 mL) was added to dilute the reaction system. The organic phase was washed with water (50 mL) and saturated brine (50 mL) in turn, and dried over anhydrous sodium sulfate. The solvent was evaporated from the filtrate under reduced pressure to obtain the compound of Formula 2. The yield was 1.784 g and the yield was 96.9%.
[0072] Comparative Example 1: Synthesis of the compound represented by Formula 2
[0073] A reaction system containing the compound of Formula 1 (1.56 g, 0.01 mol), iodomethane (5.68 g, 0.04 mol), potassium carbonate (7.60 g, 0.055 mol) and DMF (50 mL) was sealed and reacted at 95° C. for 12 hours. After the reaction, the reaction system was cooled and quenched with saturated ammonium chloride solution (10 mL). Ethyl acetate (50 mL) was added to dilute the reaction system. The organic phase was washed with water (50 mL) and saturated brine (50 mL) in turn, and dried over anhydrous sodium sulfate. The solvent was evaporated from the filtrate under reduced pressure to obtain the compound of Formula 2. The yield was 1.715 g and the yield was 93.1%.
[0074] Example 7 Synthesis of the compound represented by formula 3
[0075] To a 50mL Schlenk tube, add the compound shown in Formula 2 (1.84g, 0.01mol), NH3BH3 (0.355g, 0.0115mol), sodium bis(trimethylsilyl)amide (NaHMDS) (2.75g, 0.015mol), and THF solution (20ml) in sequence, seal the Schlenk tube, and stir the reaction at 25°C under a nitrogen atmosphere for 15 minutes. After the reaction is completed, add water (10mL) to quench the reaction, extract with ethyl acetate (20mL×2), combine the organic phases, dry over anhydrous sodium sulfate, concentrate under reduced pressure to remove the organic solvent, and directly filter to separate the solid of the compound shown in Formula 3, with an amount of 1.52g and a yield of 89.8%.
[0076] LC-MS (APCI): m / z = 170.2 (M+1) + .
[0077] Example 8 Synthesis of the compound represented by formula 3
[0078] To a 50 mL Schlenk tube, add the compound shown in Formula 2 (1.84 g, 0.01 mol), NH3BH3 (0.340 g, 0.011 mol), sodium bis(trimethylsilyl)amide (NaHMDS) (2.57 g, 0.014 mol), and THF solution (20 ml) in sequence, seal the Schlenk tube, and stir the reaction at 25°C under a nitrogen atmosphere for 14 minutes. After the reaction is completed, add water (10 mL) to quench the reaction, extract with ethyl acetate (20 mL×2), combine the organic phases, dry over anhydrous sodium sulfate, concentrate under reduced pressure to remove the organic solvent, and directly filter to separate the solid of the compound shown in Formula 3, with an amount of 1.48 g and a yield of 87.6%.
[0079] Example 9 Synthesis of the compound represented by formula 3
[0080] To a 50mL Schlenk tube, add the compound shown in Formula 2 (1.84g, 0.01mol), NH3BH3 (0.370g, 0.012mol), sodium bis(trimethylsilyl)amide (NaHMDS) (2.93g, 0.016mol), and THF solution (20ml) in sequence, seal the Schlenk tube, and stir the reaction at 25°C under a nitrogen atmosphere for 18 minutes. After the reaction is completed, add water (10mL) to quench the reaction, extract with ethyl acetate (20mL×2), combine the organic phases, dry over anhydrous sodium sulfate, concentrate under reduced pressure to remove the organic solvent, and directly filter to separate the solid of the compound shown in Formula 3, with an amount of 1.50g and a yield of 88.7%.
[0081] Comparative Example 2: Synthesis of the compound shown in Formula 3
[0082] To a 50mL Schlenk tube, add the compound shown in Formula 2 (1.84g, 0.01mol), NH3BH3 (0.309g, 0.01mol), sodium bis(trimethylsilyl)amide (NaHMDS) (2.38g, 0.013mol), and THF solution (20ml) in sequence, seal the Schlenk tube, and stir the reaction at 25°C under a nitrogen atmosphere for 15 minutes. After the reaction is completed, add water (10mL) to quench the reaction, extract with ethyl acetate (20mL×2), combine the organic phases, dry over anhydrous sodium sulfate, concentrate under reduced pressure to remove the organic solvent, and directly filter to separate the solid of the compound shown in Formula 3, with an amount of 1.43g and a yield of 84.5%.
[0083] Comparative Example 3: Synthesis of the compound shown in Formula 3
[0084] To a 50 mL Schlenk tube, add the compound shown in Formula 2 (1.84 g, 0.01 mol), NH3BH3 (0.401 g, 0.013 mol), sodium bis(trimethylsilyl)amide (NaHMDS) (3.30 g, 0.018 mol), and THF solution (20 ml) in sequence, seal the Schlenk tube, and stir the reaction at 25°C under a nitrogen atmosphere for 16 minutes. After the reaction is completed, add water (10 mL) to quench the reaction, extract with ethyl acetate (20 mL×2), combine the organic phases, dry over anhydrous sodium sulfate, concentrate under reduced pressure to remove the organic solvent, and directly filter to separate the solid of the compound shown in Formula 3, with an amount of 1.44 g and a yield of 85.1%.
[0085] Example 10 Synthesis of the compound represented by formula 4
[0086] At room temperature, toluene (200 mL) and pentamethyldiethylenetriamine (7.80 g, 0.045 mol) were added to a flask containing copper bromide (10.05 g, 0.045 mol), potassium tert-butoxide (12.90 g, 0.115 mol) and the compound of formula 3 (16.92 g, 0.1 mol). Under N2 protection, a mixed solution of the compound of formula 7 (22.60 g, 0.11 mol) and toluene (80 mL) was slowly added dropwise. , and the dripping was completed in 30 minutes. After the dripping was completed, the reaction mixture was stirred at room temperature for 8.5 hours. After the reaction was completed, ethyl acetate (200 ml) was added to dilute it. The organic phase was washed with water (200 mL) and saturated brine (200 mL) in turn, and dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent. The concentrate was purified by silica gel column chromatography using a mixed solvent of petroleum ether / ethyl acetate in a volume ratio of 10:1 to obtain the compound shown in formula 4. The yield was 22.59 g, and the yield was 76.9%.
[0087] LC-MS (APCI): m / z = 294.2 (M+1)+ .
[0088] Example 11 Synthesis of the compound represented by formula 4
[0089] At room temperature, toluene (200 mL) and pentamethyldiethylenetriamine (6.93 g, 0.04 mol) were added to a flask containing copper bromide (8.93 g, 0.04 mol), potassium tert-butoxide (12.34 g, 0.11 mol) and the compound of formula 3 (16.92 g, 0.1 mol). Under N2 protection, a mixed solution of the compound of formula 7 (20.55 g, 0.10 mol) and toluene (80 mL) was slowly added dropwise for 30 minutes. After the addition, the reaction mixture was stirred at room temperature for 8 hours. After the reaction was completed, ethyl acetate (200 ml) was added for dilution. The organic phase was washed with water (200 mL) and saturated brine (200 mL) in turn, and dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 8:1 to obtain the compound of formula 4 with an amount of 21.76 g and a yield of 74.1%.
[0090] Example 12 Synthesis of the compound represented by formula 4
[0091] At room temperature, toluene (240 mL) and pentamethyldiethylenetriamine (8.67 g, 0.05 mol) were added to a flask containing copper bromide (11.17 g, 0.05 mol), potassium tert-butoxide (13.47 g, 0.12 mol) and the compound of formula 3 (16.92 g, 0.1 mol). Under N2 protection, a mixed solution of the compound of formula 7 (24.66 g, 0.12 mol) and toluene (100 mL) was slowly added dropwise for 30 minutes. After the addition, the reaction mixture was stirred at room temperature for 9 hours. After the reaction was completed, ethyl acetate (240 ml) was added for dilution. The organic phase was washed with water (240 mL) and saturated brine (240 mL) in turn, and dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 12:1 to obtain the compound of formula 4 with an amount of 22.12 g and a yield of 75.3%.
[0092] Example 13 Synthesis of the compound represented by formula 4
[0093] At room temperature, toluene (200 mL) and pentamethyldiethylenetriamine (7.80 g, 0.045 mol) were added to a flask containing copper bromide (10.05 g, 0.045 mol), sodium tert-butoxide (11.0 g, 0.114 mol) and the compound of formula 3 (16.92 g, 0.1 mol). Under N2 protection, a mixed solution of the compound of formula 7 (22.60 g, 0.11 mol) and toluene (80 mL) was slowly added dropwise. , and the reaction mixture was added over 30 minutes. After the addition was completed, the reaction mixture was stirred at room temperature for 8.5 hours. After the reaction was completed, ethyl acetate (200 ml) was added to dilute it. The organic phase was washed with water (200 mL) and saturated brine (200 mL) in turn, and dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent. The concentrate was purified by silica gel column chromatography using a mixed solvent of petroleum ether / ethyl acetate in a volume ratio of 10:1 to obtain the compound shown in formula 4. The yield was 21.91 g, and the yield was 74.6%.
[0094] Example 14 Synthesis of the compound represented by formula 4
[0095] At room temperature, toluene (200 mL) and pentamethyldiethylenetriamine (7.80 g, 0.045 mol) were added to a flask containing copper bromide (10.05 g, 0.045 mol), butyl lithium (7.40 g, 0.116 mol) and the compound of formula 3 (16.92 g, 0.1 mol). Under N2 protection, a mixed solution of the compound of formula 7 (22.60 g, 0.11 mol) and toluene (80 mL) was slowly added dropwise for 30 minutes. After the addition, the reaction mixture was stirred at room temperature for 8.5 hours. After the reaction was completed, ethyl acetate (200 ml) was added for dilution. The organic phase was washed with water (200 mL) and saturated brine (200 mL) in turn, and dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 10:1 to obtain the compound of formula 4 with an amount of 21.71 g and a yield of 73.9%.
[0096] Comparative Example 4: Synthesis of the compound represented by Formula 4
[0097] At room temperature, toluene (200 mL) and pentamethyldiethylenetriamine (7.80 g, 0.03 mol) were added to a flask containing copper bromide (6.70 g, 0.03 mol), potassium tert-butoxide (14.59 g, 0.13 mol) and the compound shown in Formula 3 (16.92 g, 0.1 mol). Under N2 protection, a mixed solution of the compound shown in Formula 7 (26.71 g, 0.13 mol) and toluene (80 mL) was slowly added dropwise for 30 minutes. After the addition, the reaction mixture was stirred at room temperature for 8.5 hours. After the reaction was completed, ethyl acetate (200 ml) was added for dilution. The organic phase was washed with water (200 mL) and saturated brine (200 mL) in turn, and dried over anhydrous sodium sulfate. The filtrate was concentrated under reduced pressure to evaporate the solvent. The concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 4:1 to obtain the compound shown in Formula 4 with an amount of 20.18 g and a yield of 68.7%.
[0098] Example 15 Synthesis of the compound represented by formula 6
[0099] Under N2 protection, the compound represented by formula 4 (29.4 g, 0.1 mol), the compound represented by formula 5 (27.3 g, 0.11 mol), Pd(dppf)Cl2 (10.98 g, 0.015 mol) and sodium bicarbonate solution (containing 126 g (1.5 mol) of sodium bicarbonate, prepared into a 1 M solution) were added to a flask containing DMF (300 mL), and the reaction mixture was heated to 86°C to 90°C for 12 hours. After the reaction, the reaction solution was cooled to room temperature, the reaction solution was filtered through diatomaceous earth and washed with water (500 mL), the aqueous phase was extracted with ethyl acetate (500 mL×2), the organic phases were combined, washed with saturated brine (500 mL), dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 4:1 to obtain the compound represented by formula 6, with an amount of 35.71 g and a yield of 77.4%.
[0100] LC-MS (APCI): m / z = 462.3 (M+1) + .
[0101] Example 16 Synthesis of the compound represented by formula 6
[0102] Under N2 protection, the compound represented by formula 4 (29.4 g, 0.1 mol), the compound represented by formula 5 (24.8 g, 0.10 mol), Pd(dppf)Cl2 (7.32 g, 0.01 mol) and sodium bicarbonate solution (containing 126 g (1.5 mol) of sodium bicarbonate, prepared into a 1 M solution) were added to a flask containing DMF (300 mL), and the reaction mixture was heated to 90°C to 92°C for 11.5 hours. After the reaction, the reaction solution was cooled to room temperature, the reaction solution was filtered through diatomaceous earth and washed with water (500 mL), the aqueous phase was extracted with ethyl acetate (500 mL×2), the organic phases were combined, washed with saturated brine (500 mL), dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 2:1 to obtain the compound represented by formula 6, with an amount of 34.47 g and a yield of 74.7%.
[0103] Example 17 Synthesis of the compound represented by formula 6
[0104] Under N2 protection, the compound represented by formula 4 (29.4 g, 0.1 mol), the compound represented by formula 5 (29.76 g, 0.12 mol), Pd(dppf)Cl2 (14.63 g, 0.02 mol) and sodium bicarbonate solution (containing 126 g (1.5 mol) of sodium bicarbonate, prepared into a 1 M solution) were added to a flask containing DMF (300 mL), and the reaction mixture was heated to 84°C to 86°C for 13 hours. After the reaction, the reaction solution was cooled to room temperature, the reaction solution was filtered through diatomaceous earth and washed with water (500 mL), the aqueous phase was extracted with ethyl acetate (500 mL×2), the organic phases were combined, washed with saturated brine (500 mL), dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 6:1 to obtain the compound represented by formula 6, with an amount of 35.21 g and a yield of 76.3%.
[0105] Example 18 Synthesis of the compound represented by formula 6
[0106] Under N2 protection, the compound represented by formula 4 (29.4 g, 0.1 mol), the compound represented by formula 5 (27.3 g, 0.11 mol), Pd(dppf)Cl2 (10.98 g, 0.015 mol) and potassium bicarbonate solution (containing 150 g (1.5 mol) of potassium bicarbonate, prepared into a 1 M solution) were added to a flask containing DMF (300 mL), and the reaction mixture was heated to 86°C to 90°C for 12 hours. After the reaction, the reaction solution was cooled to room temperature, the reaction solution was filtered through diatomaceous earth and washed with water (500 mL), the aqueous phase was extracted with ethyl acetate (500 mL×2), the organic phases were combined, washed with saturated brine (500 mL), dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 4:1 to obtain the compound represented by formula 6, with an amount of 35.48 g and a yield of 76.9%.
[0107] Comparative Example 5: Synthesis of the compound represented by Formula 6
[0108] Under N2 protection, the compound represented by formula 4 (29.40 g, 0.1 mol), the compound represented by formula 5 (32.24 g, 0.13 mol), Pd(dppf)Cl2 (21.95 g, 0.03 mol) and sodium bicarbonate solution (containing 126 g (1.5 mol) of sodium bicarbonate, prepared into a 1 M solution) were added to a flask containing DMF (300 mL), and the reaction mixture was heated to 86°C to 90°C for 12 hours. After the reaction, the reaction solution was cooled to room temperature, the reaction solution was filtered through diatomaceous earth and washed with water (500 mL), the aqueous phase was extracted with ethyl acetate (500 mL×2), the organic phases were combined, washed with saturated brine (500 mL), dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the concentrate was purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 8:1 to obtain the compound represented by formula 6, with an amount of 33.45 g and a yield of 72.5%.
[0109] Example 19 Synthesis of the compound represented by Formula I, Pitobrutinib
[0110] The compound of formula 6 (46.14 g, 0.1 mol) and toluene (500 ml) were added to the reaction flask, the temperature was controlled below 20°C, concentrated sulfuric acid (88.2 g, 0.9 mol) was slowly added dropwise, the mixture was heated to 60°C, and the mixture was vigorously stirred for reaction for 3 hours. After the reaction solution was cooled, an ice saturated NaHCO3 (600 ml) solution was slowly added, and then ethyl acetate (2×600 mL), DCM (2×600 mL) and THF:EtOAc (v / v=1:1, 2×600 mL) were added for extraction, the organic phases were combined, washed with saturated brine (600 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid. The solid was recrystallized with a mixed solvent of ethyl acetate and hexane (the volume ratio of ethyl acetate to hexane was 6:1), filtered, and the filter cake was dried to obtain the compound of formula I, 42.91 g, a yield of 89.5%, and a HPLC purity of 99.6%.
[0111] LC-MS (ES) m / z = 480.2 (M+1) + .
[0112] Example 20 Synthesis of the compound represented by Formula I, Pitobrutinib
[0113] The compound of formula 6 (46.14 g, 0.1 mol) and toluene (500 ml) were added to the reaction flask, the temperature was controlled below 20°C, concentrated sulfuric acid (78.4 g, 0.8 mol) was slowly added dropwise, the mixture was heated to 60°C, and the mixture was vigorously stirred for reaction for 3 hours. After the reaction solution was cooled, an ice saturated NaHCO3 (600 ml) solution was slowly added, and then ethyl acetate (2×600 mL), DCM (2×600 mL) and THF:EtOAc (v / v=1:1, 2×600 mL) were added for extraction, the organic phases were combined, washed with saturated brine (600 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid. The solid was recrystallized with a mixed solvent of ethyl acetate and hexane (the volume ratio of ethyl acetate to hexane was 8:1), filtered, and the filter cake was dried to obtain the compound of formula I, 41.80 g, a yield of 87.2%, and a HPLC purity of 99.5%.
[0114] Example 21 Synthesis of the compound represented by Formula I, Pitobrutinib
[0115] The compound of formula 6 (46.14 g, 0.1 mol) and toluene (500 ml) were added to the reaction flask, the temperature was controlled below 20°C, concentrated sulfuric acid (98.0 g, 1.0 mol) was slowly added dropwise, the mixture was heated to 60°C, and the mixture was vigorously stirred for reaction for 3 hours. After the reaction solution was cooled, an ice saturated NaHCO3 (600 ml) solution was slowly added, and then ethyl acetate (2×600 mL), DCM (2×600 mL) and THF:EtOAc (v / v=1:1, 2×600 mL) were added for extraction, the organic phases were combined, washed with saturated brine (600 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid. The solid was recrystallized with a mixed solvent of ethyl acetate and hexane (the volume ratio of ethyl acetate to hexane was 5:1), filtered, and the filter cake was dried to obtain the compound of formula I, 42.48 g, a yield of 88.6%, and a HPLC purity of 99.3%.
[0116] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example", or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, without contradiction.
[0117] Although the embodiments of the present invention have been shown and described above, it is to be understood that the above embodiments are exemplary and are not to be construed as limitations of the present invention. A person skilled in the art may change, modify, replace and vary the above embodiments within the scope of the present invention.
Claims
1. A method for synthesizing Pitobrutinib, characterized in that: include: (1) contacting the compound represented by Formula 1, methyl iodide, and an acid-binding agent A to obtain the compound represented by Formula 2; (2) contacting the compound represented by Formula 2 with NH3BH3 and sodium bis(trimethylsilyl)amide to obtain the compound represented by Formula 3; (3) contacting the compound represented by Formula 3, pentamethyldiethylenetriamine (PMDETA), copper bromide, an organic base B, and the compound represented by Formula 7 to obtain the compound represented by Formula 4; (4) contacting the compound represented by Formula 4, the compound represented by Formula 5, Pd(dppf)Cl2, and an inorganic salt C to obtain the compound represented by Formula 6; (5) contacting the compound of formula 5 with concentrated sulfuric acid to obtain the compound of formula I, Pitobrutinib, In step (1), the acid binding agent A is at least one selected from potassium carbonate, N,N-diisopropylethylamine, N,N-diisopropylethylenediamine or triethylamine; In step (3), the organic base B is at least one selected from potassium tert-butoxide, sodium tert-butoxide or butyl lithium; In step (4), the inorganic salt C is at least one selected from sodium bicarbonate or potassium bicarbonate.
2. The method according to claim 1, characterized in that: In step (1), the following steps are included: sealing a reaction system containing the compound of formula 1, methyl iodide, an acid-binding agent A and DMF, reacting at 100° C. for 10 hours, cooling the reaction system after the reaction is completed, performing post-treatment, quenching with a saturated ammonium chloride solution, adding ethyl acetate to dilute, washing the organic phase with water and saturated brine in sequence, drying over anhydrous sodium sulfate, and removing the solvent from the filtrate under reduced pressure to obtain the compound of formula 2; Optionally, in step (1), the molar ratio of the compound represented by formula 1, methyl iodide and acid-binding agent A is 1:4:(4.0-5.0), preferably the molar ratio of the compound represented by formula 1, methyl iodide and acid-binding agent A is 1:4:4.5; Optionally, in step (1), the acid-binding agent A is at least one selected from potassium carbonate, N,N-diisopropylethylamine, N,N-diisopropylethylenediamine or triethylamine.
3. The method according to claim 1, characterized in that In step (2), the following steps are included: adding the compound shown in formula 2, NH3BH3, sodium bis(trimethylsilyl)amide, and THF solution to a Schlenk tube in sequence, sealing the Schlenk tube, stirring and reacting at 25°C under a nitrogen atmosphere for 14 to 18 minutes, after the reaction is completed, adding water to quench the reaction, extracting with ethyl acetate, combining the organic phases, drying over anhydrous sodium sulfate, concentrating under reduced pressure to remove the organic solvent, and directly filtering to separate the compound shown in formula 3.
4. The method according to claim 3, characterized in that In step (2), the molar ratio of the compound represented by formula 2 to NH3BH3 and sodium bis(trimethylsilyl)amide is 1:(1.1-1.2):(1.4-1.6), preferably the molar ratio of the compound represented by formula 2 to NH3BH3 and sodium bis(trimethylsilyl)amide is 1:1.15:1.5; Optionally, in step (2), the reaction is preferably stirred for 15 minutes.
5. The method according to claim 1, characterized in that In step (3), the following steps are included: at room temperature, toluene and pentamethyldiethylenetriamine are added to a flask containing copper bromide, an organic base B and the compound shown in formula 3; under N2 protection, a mixed solution of the compound shown in formula 7 and toluene is slowly added dropwise for 30 minutes; after the addition is completed, the reaction mixture is stirred at room temperature for 8 to 9 hours; after the reaction is completed, ethyl acetate is added for dilution; the organic phase is washed with water and saturated brine in sequence, dried over anhydrous sodium sulfate, the filtrate is concentrated under reduced pressure to evaporate the solvent, and the concentrate is purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of (8 to 12):1 to obtain a compound shown in formula 4; Optionally, in step (3), the molar ratio of the compound represented by formula 3, pentamethyldiethylenetriamine, copper bromide, organic base B, and the compound represented by formula 7 is 1:(0.04-0.05):(0.04-0.05):(1.1-1.2):(1.0-1.2), preferably the molar ratio of the compound represented by formula 3, pentamethyldiethylenetriamine, copper bromide, organic base B, and the compound represented by formula 7 is 1:0.045:0.045:1.15:1.1; Optionally, in step (3), the organic base B is at least one selected from potassium tert-butoxide, sodium tert-butoxide or butyl lithium; Optionally, in step (3), the reaction mixture is preferably stirred at room temperature for 8.5 hours; Optionally, in step (3), the volume ratio of petroleum ether / ethyl acetate mixed solvent is preferably 10:
1.
6. The method according to claim 1, characterized in that In step (4), the following steps are included: under N2 protection, the compound shown in formula 4, the compound shown in formula 5, Pd(dppf)Cl2 and inorganic salt C solution are added to a flask containing DMF, the reaction mixture is heated to 84°C to 92°C and reacted for 11.5 hours to 13 hours. After the reaction is completed, the reaction solution is cooled to room temperature, the reaction solution is filtered through diatomaceous earth and then washed with water, the aqueous phase is extracted with ethyl acetate, the organic phases are combined and then washed with saturated brine, dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the concentrate is purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of (2 to 6):1 to obtain a compound shown in formula 6.
7. The method according to claim 6, characterized in that In step (4), the molar ratio of the compound represented by formula 4, the compound represented by formula 5, Pd(dppf)Cl2, and the inorganic salt C is 1:(1.0-1.2):(0.1-0.2):15, preferably the molar ratio of the compound represented by formula 4, the compound represented by formula 5, Pd(dppf)Cl2, and the inorganic salt C is 1:1.1:0.15:15; Optionally, in step (4), the inorganic salt C is at least one selected from sodium bicarbonate or potassium bicarbonate; Optionally, in step (4), the reaction mixture is preferably heated to 86°C to 90°C for 12 hours; Optionally, in step (4), the volume ratio of petroleum ether / ethyl acetate mixed solvent is preferably 4:
1.
8. The method according to claim 1, characterized in that In step (5), the following steps are included: adding the compound shown in formula 6 and toluene to a reaction bottle, controlling the temperature below 20°C, slowly dropping concentrated sulfuric acid, and after the dropping is completed, the mixed solution is heated to 60°C and vigorously stirred for reaction for 3 hours. After the reaction solution is cooled, post-treatment is performed, and an ice saturated NaHCO3 solution is slowly added, and then ethyl acetate, DCM and THF:EtOAc (v / v=1:1) are added respectively for extraction. After the organic phases are combined, saturated brine is added for washing, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid, and the solid is recrystallized with a mixed solvent of ethyl acetate and hexane, filtered, and the filter cake is dried to obtain the compound shown in formula I, Pirotbrutinib.
9. The method according to claim 8, characterized in that In step (5), the molar ratio of the compound represented by formula 6 to concentrated sulfuric acid is 1:(8-10), preferably the molar ratio of the compound represented by formula 6 to concentrated sulfuric acid is 1:9; Optionally, in step (5), the volume ratio of ethyl acetate to hexane in the mixed solvent of ethyl acetate and hexane is (5-8):1, preferably the volume ratio of ethyl acetate to hexane is 6:
1.
10. The method according to claim 1, characterized in that In step (1), the following steps are included: sealing a reaction system containing the compound represented by formula 1 (1.56 g, 0.01 mol), iodomethane (5.68 g, 0.04 mol), potassium carbonate (6.22 g, 0.045 mol) and DMF (50 mL), reacting at 100° C. for 10 hours, cooling the reaction system after the reaction is completed, quenching with saturated ammonium chloride solution (10 mL), adding ethyl acetate (50 mL) to dilute, washing the organic phase with water (50 mL) and saturated brine (50 mL) in sequence, drying over anhydrous sodium sulfate, and distilling off the solvent from the filtrate under reduced pressure to obtain the compound represented by formula 2, with an amount of 1.810 g and a yield of 98.3%; In step (2), the following steps are included: adding the compound represented by formula 2 (1.84 g, 0.01 mol), NH3BH3 (0.355 g, 0.0115 mol), sodium bis(trimethylsilyl)amide (2.75 g, 0.015 mol), and THF solution (20 ml) to a 50 mL Schlenk tube in sequence, sealing the Schlenk tube, stirring and reacting at 25° C. under a nitrogen atmosphere for 15 minutes, after the reaction is completed, adding water (10 mL) to quench the reaction, extracting with ethyl acetate (20 mL×2), combining the organic phases, drying over anhydrous sodium sulfate, concentrating under reduced pressure to remove the organic solvent, and directly filtering to separate the solid of the compound represented by formula 3, with an amount of 1.52 g and a yield of 89.8%; In step (3), the following steps are included: at room temperature, toluene (200 mL) and pentamethyldiethylenetriamine (7.80 g, 0.045 mol) are added to a flask containing copper bromide (10.05 g, 0.045 mol), potassium tert-butoxide (12.90 g, 0.115 mol) and the compound represented by formula 3 (16.92 g, 0.1 mol), and under N2 protection, a mixed solution of the compound represented by formula 7 (22.60 g, 0.11 mol) and toluene (80 mL) is slowly added dropwise for 30 minutes. After the addition is completed, the reaction mixture is stirred at room temperature for 8.5 hours. After the reaction is completed, ethyl acetate (200 ml) is added for dilution, the organic phase is washed with water (200 mL) and saturated brine (200 mL) in sequence, and dried over anhydrous sodium sulfate. The filtrate is concentrated under reduced pressure to evaporate the solvent, and the concentrate is concentrated with a volume ratio of 10:1 petroleum ether / ethyl acetate mixed solvent, Purification by silica gel column chromatography gave the compound of formula 4, yield 22.59 g , yield 76.9%; In step (4), the following steps are included: under N2 protection, the compound represented by formula 4 (29.4 g, 0.1 mol), the compound represented by formula 5 (27.3 g, 0.11 mol), Pd(dppf)Cl2 (10.98 g, 0.015 mol) and sodium bicarbonate solution (containing 126 g (1.5 mol) of sodium bicarbonate, prepared into a 1 M solution) are added to a flask containing DMF (300 mL), the reaction mixture is heated to 86°C to 90°C for reaction for 12 hours, after the reaction is completed, the reaction solution is cooled to room temperature, the reaction solution is filtered through diatomaceous earth and then washed with water (500 mL), the aqueous phase is extracted with ethyl acetate (500 mL×2), the organic phases are combined and then washed with saturated brine (500 mL), dried over anhydrous sodium sulfate, concentrated under reduced pressure, and the concentrate is purified by silica gel column chromatography using a petroleum ether / ethyl acetate mixed solvent with a volume ratio of 4:1 to obtain a compound represented by formula 6, with an amount of 35.71 g and a yield of 77.4%; In step (5), the following steps are included: adding the compound represented by formula 6 (46.14 g, 0.1 mol) and toluene (500 ml) to a reaction bottle, controlling the temperature below 20°C, slowly dropping concentrated sulfuric acid (88.2 g, 0.9 mol), and after the dropping is completed, the mixed solution is heated to 60°C and stirred vigorously for 3 hours. After the reaction solution is cooled, an ice-saturated NaHCO3 (600 ml) solution is slowly added, and then ethyl acetate (2×600 mL), DCM (2 × 600 mL) and THF:EtOAc (v / v=1:1, 2×600 mL), the organic phases were combined, washed with saturated brine (600 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid, which was recrystallized from a mixed solvent of ethyl acetate and hexane (the volume ratio of ethyl acetate to hexane was 6:1), filtered, and the filter cake was dried to obtain the compound of formula I, pitobrutinib, with an yield of 42.91 g, a yield of 89.5%, and a HPLC purity of 99.6%.
Citation Information
Patent Citations
Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and / or IFN alpha responses
CN104884454A
Selective GRP94 inhibitors and uses thereof
CN105899503A
Quinoline compounds and pharmaceutical compositions and uses thereof
CN113767099A
Amide derivative and application thereof in medicine
CN114920690A
Process and intermediates for preparation of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido) methyl) phenyl)-1-(1, 1, 1-trifluoropropyl-2-yl)-1h-pyrazol-4-carboxamide
CN116323553A
